Gary Schiller, MD, UCLA Medical Center
Advertisement
Articles by Gary Schiller, MD, UCLA Medical Center
Advertisement
Latest Updated Articles
Standard of Care for BPDCN TreatmentPublished: August 20th 2020 | Updated:
Novel Agents for BPDCN ManagementPublished: August 20th 2020 | Updated:
Treatment Approach Amid COVID-19 PandemicPublished: August 20th 2020 | Updated:
Second-Line Treatment OptionsPublished: August 20th 2020 | Updated:
BPDCN Prevalence, Patient Profile, and Work-UpPublished: August 20th 2020 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
Single-Center, Retrospective Data Show Low Rate of Lifileucel Infusion Following Referral in Advanced Melanoma
2
Outcomes With Bridging Therapy Correlate With Cilta-Cel Efficacy, Safety in Multiple Myeloma
3
Real-World Data Support Clinical Benefit With Lifileucel in Previously Treated Advanced Melanoma
4
Long-Term Cilta-Cel Data Show Low Rates of PFS Events in Standard-Risk R/R Myeloma
5